A single centre experience of low dose direct oral anticoagulants (DOAC) after unprovoked venous thromboembolism (VTE)

Conclusion: At our centre, 63% of patients are treated with low dose DOAC and an average follow-up of more than a year showed low VTE recurrence and major bleeding rates. Larger trials are awaited

http://erj.ersjournals.com/cgi/content/short/54/suppl_63/PA1457?rss=1

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Thomas, W., Symington, E., Besser, M., Sheares, K. Tags: Pulmonary embolism Source Type: research